Magnet Biomedicine and Lilly to Develop Novel Molecular Glue Medicines
The collaboration will leverage Magnet's TrueGlue™ discovery platform to identify molecular glues capable of inducing protein proximity and cooperativity, enabling novel mechanisms of action to address difficult-to-drug targets spanning multiple diseases with unmet medical need.
Lilly | 01/03/2025 | By Aishwarya
Lilly Signs Deal with EVA Pharma to Expand Access to baricitinib
This collaboration is part of the Lilly 30x30 initiative, which aims to improve access to quality health care for 30 million people living in resource-limited settings annually by 2030.
Lilly | 05/09/2024 | By Aishwarya | 226
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy